Change at Pfizer: Jeff Kindler (A) Harvard Case Solution & Analysis

Pfizer Inc, the largest research company in the world of drugs, is facing numerous challenges. Key tasks include heavy fighting court with general companies for patent Lipitor, reduced productivity of research and development, as well as changes in the environment of health on a global scale with the growing importance of emerging markets. These problems are in the business environment is characterized by the most multi-level change and uncertainty. The case remains on strategy appointed Chief Executive Officer in the transformation of the giant pharmaceutical organization by changing the business model, strategy and structure to support organic growth, as well as to understand the external features. Is there Pfizer needs more changes, or it is just a matter of time before the new strategy generates results? "Hide
by Michael Rose Source: Richard Ivey School of Business Foundation 26 pages. Publication Date: January 27, 2010. Prod. #: 910M14-PDF-ENG

Share This

SALE SALE

Save Up To

30%

IN ONLINE CASE STUDY

FOR FREE CASES AND PROJECTS INCLUDING EXCITING DEALS PLEASE REGISTER YOURSELF !!

Register now and save up to 30%.